SHERP

Economic Evaluation And Pharmaceutical Reimbursement Reform In South Korea's National Health Insurance

Cited 0 time in webofscience Cited 43 time in scopus
Authors
Yang, Bong-min; Bae, Eun-young; Kim, Jinhyun
Issue Date
2008
Publisher
Project HOPE
Citation
Health Affairs 27, no.1 (2008): 179-187
Abstract
South Korea’s National Health Insurance recently announced a reform in pharmaceutical reimbursement, with the purpose of increasing rational resource use in drug spending. The new policy aims to take the cost-effectiveness and budget impact of newly introduced drugs into account in payment decisions. If the policy is implemented, South Korea will be the first Asian country to officially adopt economic evaluation as a tool for resource allocation in health care. This paper looks at the background, objectives, expected outcomes, potential issues, and resulting trade conflict regarding use of economic data in drug reimbursement decisions in South Korea.
ISSN
0278-2715
Language
English
URI
http://hdl.handle.net/10371/9795
DOI
https://doi.org/10.1377/hlthaff.27.1.179
Files in This Item:
Appears in Collections:
College of Nursing (간호대학)Dept. of Nursing (간호학과)Journal Papers (저널논문_간호학과)
  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse